NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE114807 Query DataSets for GSE114807
Status Public on May 01, 2020
Title DNA methylation data from Human Mammary Epithelial Cells (HMECs) transduced with shp53, HRASV12, WNT1 and CCNE1 [RRBS-seq]
Organism Homo sapiens
Experiment type Methylation profiling by high throughput sequencing
Summary Gene expression differences, combined with distinct patterns of genomic rearrangements and epigenetic modifications constitute the bases of molecular classification of breast cancer. Molecular subtypes may originate from different cell lineages in the mammary gland, but also from the early activation of oncogenes that may drive the establishment of these molecular subtypes. However, in the natural history of human cancer, it is difficult to discriminate between these two factors : cell lineage and initial oncogenic alterations. In this work, we designed an experimental strategy aiming at determining whether activation of distinct oncogenic pathways in human mammary epithelial cells (HMEC) could lead to different patterns of genetic and epigenetic changes. This work suggests that the early activation of oncogenes is an important determinant of the establishment of breast cancer molecular subtypes along with cell lineage origin.
 
Overall design In this work, we overexpressed by retroviral transduction three oncogenes WNT1, CCNE1 and RASv12, known to activate different oncogenic pathways, in shp53 immortalized human HMECs and monitored epigenetic and genetic changes at different steps of cell progression.
All samples are in biological duplicates. Primary HMECs are named R2. Two samples correspond to HMECs shortly after shP53 transduction (R2shP53_Early) and several weeks after shP53 transduction (R2shP53_Late). HMECs transduced with oncogenes (either HRASV12, WNT1 or CCNE1) are named R2shp53-ONCOGENE_Late. Finaly, HMECs transduced with oncogenes were also grown in soft agar and are named R2shp53-ONCOGENE_SA after selection in soft agar.
 
Contributor(s) Theillet C, du Manoir S, Sardet C, Weber M, Orsetti B, Fonti C, Saumet A
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date May 23, 2018
Last update date May 03, 2020
Contact name stanislas P du manoir
E-mail(s) stanislas.dumanoir@inserm.fr
Organization name IRCM
Lab Genetic and phenotypic plasticity of cancer team
Street address 280 rue des apothicaires
City montpellier
ZIP/Postal code 34298
Country France
 
Platforms (1)
GPL11154 Illumina HiSeq 2000 (Homo sapiens)
Samples (18)
GSM3150564 RRBS_R2_replicate1
GSM3150565 RRBS_R2_replicate2
GSM3150566 RRBS_R2shP53_Early_replicate1
This SubSeries is part of SuperSeries:
GSE114849 DNA methylation and mirRNA/mRNA Expression data from Human Mammary Epithelial Cells (HMECs) transduced with shp53, HRASV12, WNT1 and CCNE1
Relations
BioProject PRJNA472704
SRA SRP148776

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE114807_RAW.tar 302.4 Mb (http)(custom) TAR (of IGV)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap